Skip to main content

Polycythemia Vera clinical trials at UCSF

1 research study open to eligible people

Polycythemia vera is a disease where your body makes too many red blood cells. UCSF is studying a drug called rusfertide to see if it can help control this. The trial will check if rusfertide is safe and if it works well for patients.

Showing trials for
  • Rusfertide in Patients With Polycythemia Vera

    open to eligible people ages 18 years and up

    The study is designed to evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera (PV) in maintaining hematocrit control and in improving symptoms of PV.

    San Francisco, California and other locations

Last updated: